Pefachrome(R) fxa*

Pefachrome(R) fxa* is a specialized chromogenic substrate designed for the quantitative measurement of Factor Xa activity in a variety of biochemical and research settings. Engineered for high specificity and sensitivity, Pefachrome(R) fxa* enables accurate detection and monitoring of serine protease activity, particularly within the coagulation cascade. Its unique peptide sequence and chromogenic reporter system allow for rapid and reliable colorimetric readouts, making it a valuable tool for laboratories engaged in hemostasis research, enzymology, and drug discovery. The substrate is formulated to provide consistent performance under diverse assay conditions, supporting both manual and automated workflows. By delivering robust and reproducible results, Pefachrome(R) fxa* facilitates the advancement of scientific understanding in coagulation mechanisms and related biochemical pathways.

Coagulation Research: In the field of coagulation research, Pefachrome(R) fxa* is widely employed for the assessment of Factor Xa generation and inhibition. Researchers utilize this substrate in kinetic assays to monitor the enzymatic activity of Factor Xa, a key serine protease in the blood coagulation cascade. By providing a direct and sensitive measure of enzymatic conversion, the substrate enables detailed studies of coagulation dynamics, supporting the investigation of physiological and pathological processes such as thrombosis and hemostasis. The chromogenic readout simplifies quantification, making it easier to compare results across different experimental conditions and to evaluate the effects of potential anticoagulant compounds.

Enzyme Kinetics Studies: For those investigating the kinetics of serine proteases, Pefachrome(R) fxa* serves as a reliable substrate for detailed enzymatic profiling. It allows for the precise determination of kinetic parameters, including Km and Vmax, by providing a measurable chromogenic signal upon cleavage by Factor Xa. This application is critical for understanding enzyme-substrate interactions, characterizing mutant or modified forms of Factor Xa, and elucidating the molecular basis of enzyme regulation. The substrate's compatibility with a range of buffer systems and experimental formats ensures flexibility and accuracy in kinetic measurements.

Anticoagulant Drug Screening: In pharmaceutical research, Pefachrome(R) fxa* is indispensable for high-throughput screening of Factor Xa inhibitors. Drug developers leverage its rapid and quantifiable colorimetric response to evaluate the potency and specificity of new anticoagulant candidates targeting Factor Xa. By incorporating the substrate into automated screening platforms, researchers can efficiently assess large compound libraries, accelerating the identification of promising therapeutic agents. The substrate's selectivity minimizes background interference, thereby improving the reliability of inhibitor profiling and supporting structure-activity relationship studies.

Biomarker Discovery: Another important application of Pefachrome(R) fxa* is in the discovery and validation of biomarkers related to coagulation disorders. Scientists employ the substrate in plasma-based assays to detect aberrant Factor Xa activity, which may signal underlying coagulopathies or disease states. By enabling sensitive detection of enzymatic changes, the substrate supports the identification of novel diagnostic or prognostic markers. Its adaptability to various assay formats, including microplate-based and point-of-care devices, broadens its utility in translational research and biomarker validation studies.

Functional Protein Analysis: Pefachrome(R) fxa* also finds utility in the functional analysis of recombinant or purified proteins involved in the coagulation pathway. Researchers use it to verify the activity of expressed Factor Xa or to assess the functional consequences of protein engineering efforts. The chromogenic substrate provides a straightforward method for confirming the presence of active enzyme and for comparing the activity of different protein constructs. This application is particularly valuable in the development and quality control of research reagents, as well as in the study of protein-protein interactions within the coagulation cascade. By supporting these diverse research directions, Pefachrome(R) fxa* continues to be a cornerstone reagent for advancing knowledge in enzymology and hemostasis-related science.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines